Cancer cell-derived exosome based dual-targeted drug delivery system for non-small cell lung cancer therapy
- 5 August 2024
- journal article
- research article
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 244, 114141
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Unravelling KDM4 histone demethylase inhibitors for cancer therapyDrug Discovery Today, 2021
- The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challengesBiomedicine & Pharmacotherapy, 2021
- Mechanisms of resistance to chemotherapy in non-small cell lung cancerArchives of Pharmacal Research, 2021
- The role of high‐density lipoproteins in antitumor drug deliveryIUBMB Life, 2019
- Augmented liver targeting of exosomes by surface modification with cationized pullulanActa Biomaterialia, 2017
- Developing A Small Cell Lung Cancer Conceptual Model to Inform Treatment Outcome and Assessment Strategy Decisions in Clinical ResearchValue in Health, 2016
- Synthesis and characterization of poly(lactic acid)-modified superparamagnetic iron oxide nanoparticlesJournal of Sol-Gel Science and Technology, 2015
- Superparamagnetic iron oxide nanoparticles coated with different polymers and their MRI contrast effects in the mouse brainsApplied Surface Science, 2015
- Synthesis of poly(ethylene glycol) and poly(vinyl pyrrolidone) co-coated superparamagnetic iron oxide nanoparticle as a pH-sensitive release drug carrierColloids and Surfaces A: Physicochemical and Engineering Aspects, 2013
- Transferrin-conjugated, fluorescein-loaded magnetic nanoparticles for targeted delivery across the blood–brain barrierJournal of Materials Science: Materials in Medicine, 2013